Hyperglycaemia Clinical Trials

17 recruiting

Hyperglycaemia Trials at a Glance

16 actively recruiting trials for hyperglycaemia are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Aurora, Copenhagen, and Detroit. Lead sponsors running hyperglycaemia studies include David K Carroll, Deakin University, and Bo Feldt-Rasmussen.

Browse hyperglycaemia trials by phase

Treatments under study

About Hyperglycaemia Clinical Trials

Looking for clinical trials for Hyperglycaemia? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperglycaemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperglycaemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Phase 1Phase 2

Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

Diabetes (DM)Diabetic KetoacidosisKetosis Prone Diabetes+1 more
David K Carroll60 enrolled1 locationNCT07167693
Recruiting
Not Applicable

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

Diabetes MellitusOxidative StressHyperglycaemia (Diabetic)+4 more
Vastra Gotaland Region150 enrolled2 locationsNCT06984822
Recruiting
Not Applicable

Effects of Lean Pork Loin Intake on Protein Homeostasis and Glucose Regulation in Prediabetic Adults

PrediabetesHyperglycaemia (Non Diabetic)
University of Arkansas20 enrolled1 locationNCT06025292
Recruiting
Not Applicable

Developing an AI Pharmacy Chatbot for the Population of Hong Kong

Artificial Intelligence (AI)HypertensionHyperglycaemia+1 more
The University of Hong Kong280 enrolled2 locationsNCT07037563
Recruiting
Not Applicable

Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM

Diabetes Type 2Hyperglycaemia (Diabetic)QT Interval, Variation in+1 more
Richmond Pharmacology Limited24 enrolled1 locationNCT07014735
Recruiting
Phase 4

Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)

Overweight and ObesityHyperglycaemia (Diabetic)Type 2 Diabetes Patients
The First Affiliated Hospital of Xiamen University164 enrolled1 locationNCT03087032
Recruiting

Continuous Glucose Monitoring (CGM) After Kidney Transplantation

Kidney TransplantationHyperglycaemia
Bo Feldt-Rasmussen54 enrolled1 locationNCT06675903
Recruiting
Phase 4

Insulin Therapy for Postreperfusion Hyperglycemia

Liver TransplantationHyperglycaemia (Diabetic)
Seoul National University Hospital20 enrolled1 locationNCT03152890
Recruiting
Not Applicable

Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes

Type 1 DiabetesHypoglycemiaHyperglycaemia Due to Type 1 Diabetes Mellitus+1 more
University of Colorado, Denver150 enrolled1 locationNCT06297980
Recruiting

Whole body vibration exercise and type 2 diabetes

Diminished exercise capacityHyperglycaemia
Deakin University40 enrolled1 locationACTRN12622001052729
Recruiting

REDuced CARBohydrate enteral formula compared to standard care in hyperglycaemic critically ill tube fed patients – a randomised controlled phase II trial

Hyperglycaemia
The University of Queensland160 enrolled8 locationsACTRN12621000859886
Recruiting

Specialist Treatment of Inpatients: Caring for Diabetes (STOIC-D) - A single centre, randomised, controlled trial assessing the impact of a proactive specialist inpatient diabetes service on outcomes in inpatients with diabetes or hyperglycaemia.

Hyperglycaemia
Melbourne Health2,884 enrolled1 locationACTRN12620001303932
Recruiting

Hyperglycaemia in Neonates Trial: Computer determined insulin dosage in the management of neonatal hyperglycaemia

Neonatal Hyperglycaemia
University of Auckland; Department of Paediatrics: Child and Youth Health138 enrolled1 locationACTRN12614000492651
Recruiting

The significance of hyperglycaemia in survivors of critical illness and potential mechanisms underlying development of type 2 diabetes

Type 2 DiabetesCritical IllnessHyperglycaemia
Dr Adam Deane600 enrolled1 locationACTRN12614000449639
Recruiting
Phase 2

The Effect of Prolonged Glucagon-like Peptide 1 Infusion on Gastric Emptying in Healthy Volunteers

Critical Illness Induced HyperglycaemiaDiabetesHyperglycaemia
Mahesh Umapathysivam10 enrolled1 locationACTRN12612001035819
Recruiting

Stochastic Targeted Glycemic Control in the Intensive Care Unit Pilot Trials

Stress-induced Hyperglycaemia
Dr Geoffrey M Shaw30 enrolled1 locationACTRN12611001261909